Broadfin Capital’s Dentsply Sirona XRAY Stock Holding History

Broadfin Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-262,900	Closed	-$11.5M	–	56
2018 Q2	$11.5M	Buy	+262,900	New	+$12.3M	1.81%	21

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Broadfin Capital's XRAY Position: Q3 2018 in Review

Broadfin Capital sold out of Dentsply Sirona (XRAY) in Q3 2018, closing a stake of 262,900 shares — an estimated $11.5M sold.

Broadfin Capital first reported a position in XRAY in Q2 2018 and held it in 1 quarter. The position peaked at $11.5M in Q2 2018. 521 funds tracked by Wall St. Rank hold XRAY as of Q3 2018.

Broadfin Capital reported no remaining Dentsply Sirona position as of Q3 2018 after selling out during the quarter.
Broadfin Capital sold 262,900 Dentsply Sirona shares in Q3 2018, an estimated $11.5M.
Broadfin Capital first reported a position in Dentsply Sirona in Q2 2018 and held it in 1 quarter.
Broadfin Capital's Dentsply Sirona position peaked at $11.5M in Q2 2018.
521 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2018.

Based on Broadfin Capital's 13F filing for Q3 2018, filed 14 Nov 2018.